Groundbreaking Inhalation Therapy for COVID-19 Treatment
Groundbreaking Inhalation Therapy for COVID-19 Treatment - OPP.Today
Stay updated with breaking news from Dimmune Biosolutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Groundbreaking Inhalation Therapy for COVID-19 Treatment - OPP.Today
A cocktail of antibodies developed by Quebec firm Immune Biosolutions has reportedly proved effective in alleviating the respiratory symptoms caused by COVID-19 during the acute phase of the virus.
Monoclonal antibodies that millions of Americans rely on to treat the coronavirus are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are more potent and more resistant to new variants.
"Monoclonals had their day, like the Model T or the biplane," Carl Dieffenbach, director of the Division of AIDS at the National Institutes of Health and lead of the NIH's Antiviral Program for Pandemics.
Lab-made therapies are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are both more potent and more resistant to new variants.